Month: July 2023

DS_logo_portrait_format_4color_rgb_120206-4

ENHERTU® Demonstrated Clinically Meaningful Progression-Free Survival and Overall Survival Across Multiple HER2 Expressing Advanced Solid Tumors in DESTINY-PanTumor02 Phase 2 Trial

Data support ongoing discussions with global health authorities TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Topline results from the primary analysis of...